1. 胡晶, 李博, 张会娜, 冯硕, 廖星*.中医药随机对照试验中采用真实世界数据作为对照组的研究设计及挑战.中国实验方剂学杂志.2023.29(1).181-187.核心期刊 |
2. 戴泽琦, 徐思敏, 吴雪, 李苗苗, 胡晶*, 廖星*.多准则决策分析用于中成药临床综合评价的建议.中国中药杂志.2022.47(12).3155-3160.核心期刊 |
3. Jing Hu, Huina Zhang, Shuo Feng, Bo Li*.Application of comprehensive evaluation methods in the clinical efficacy evaluation of traditional Chinese medicine: a narrative review.Longhua Chinese Medicine.2022.5(25).lcm-21-63. |
4. Zeqi Dai#, Simin Xu#, Xue Wu, Ruixue Hu, Huimin Li, Haoqiang He, Jing Hu*, Xing Liao*.Knowledge Mapping of Multicriteria Decision Analysis in Healthcare: A Bibliometric Analysis.Frontiers in Public Health.2022.10.1-9.SCI |
5. 冯硕, 李博, 张会娜, 马继征, 付渊博, 张涛, 胡晶*.针刺临床试验的安慰剂对照及其方法学问题.中国针灸.2022.42(4).437-441.核心期刊 |
6. Huimin Li, Ruixue Hu, Simin Xu, Zeqi Dai, Xue Wu, Jing Hu*, Xing Liao*.Tripterygium wilfordii Hook. f. Preparations for Rheumatoid Arthritis: An Overview of Systematic Reviews.Evidence-Based Complementary and Alternative Medicine.2022.2022.1-8.SCI |
7. Jing Hu,Shuo Feng,Xiaoli Zhang,Huina Zhang,Yanxiang Ha,Chongyang Wei,Xuejiao Wang,Rui Zhang ,Xing Liao*, Bo Li*.The Use of Multiple Primary Outcomes in Randomized Controlled Trials of Chinese Herbal Medicine.Evidence-Based Complementary and Alternative Medicine.2021.2021.9975351.SCI |
8. 胡晶,高双庆,王阶,李军,陈恒文,戴泽琦*,廖星*.脑梗死与冠心病患者使用血栓心脉宁片的疾病负担及直接医疗费用分析.中国中药杂志.2021.46(9).2309-2316.核心期刊 |
9. 胡晶,李博,张会娜,刘卫红,冯硕*.针灸临床试验的样本量估计.中国针灸.2021.41(10).1147-1152.核心期刊 |
10. 胡瑞学,于丹丹,李慧敏,顾浩,赵晖,许海玉,李兵,胡晶*,廖星*.基于2种复杂网络分析方法探索活血化瘀类中药注射液治疗急性脑梗死的疗效.中国中药杂志.2021.46(14).3722-3731.核心期刊 |
11. Jing Hu, Hui-Na Zhang, Shuo Feng, Yan-Xiang Ha, Chong-Yang Wei, Xue-Jiao Wang, Rui Zhang, Bo Li*.Randomized controlled trials of Chinese herbal medicine published in English from 2010 to 2019: a bibliometrics study.Annals of Palliative Medicine.2021.10(12).12945-12954.SCI |
12. 廖星,胡瑞学,李博,胡晶*,褚红玲,尹学珺,陈薇,章轶立*.混合方法研究评价工具的介绍——MMAT.中国全科医学.2021.24(31).4015-4020.核心期刊 |
13. 胡晶,张会娜,李博,冯硕,哈雁翔,韦重阳,王雪娇,张瑞,王巍巍*.以英文发表的口服中药随机对照试验中不良事件及其影响因素的分析.中国中药杂志.2020.45(8).1948-1952.核心期刊 |
14. Jing Hu, Huina Zhang, Shuo Feng, Yanxiang Ha, Chongyang Wei, Xuejiao Wang, Rui Zhang, Bo Li*.The safety of Chinese herbal medicine: a systematic review of adverse events in randomized controlled trial.Longhua Chinese Medicine.2020.2020.lcm-20-23. |
15. 胡晶,张会娜,李博,冯硕.临床流行病学在中医科研教学中的思考.继续医学教育.2018.32(2).76-77.核心期刊 |
16. 胡晶,冯硕,李博,张会娜,商洪才*.处方序列对称分析在研究中药注射剂不良反应中的应用展望.世界科学技术-中医药现代化.2018.20(10).1739-1744.核心期刊 |
17. 胡晶, 孙凤*, 詹思延.偏倚风险评估系列:(八) 系统综述.中华流行病学杂志.2018.39(8).1125-1129.核心期刊 |
18. Jing Hu, Shuo Liu, Weihong Liu, Huina Zhang, Jing Chen, Hongcai Shang*.Establishing an evaluation mode with multiple primary outcomes based on combination of diseases and symptoms in TCM clinical trials.Annals of Translational Medicine.2017.5(21).1-6.SCI |